Medtronic Completes Separation of MiniMed Group
Medtronic has finished spinning off MiniMed. It exchanged its entire remaining stake of 252.8 million MiniMed shares in an offer that was 5.4 times oversubscribed.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Medtronic plc said it has completed the separation of MiniMed Group, Inc., whose shares trade on Nasdaq under the ticker MMED. Medtronic exchanged its entire remaining stake in MiniMed, 252,813,348 shares, through an offer to swap them for Medtronic ordinary shares. Demand for the offer was 5.4 times the amount on offer.
Medtronic Chairman and CEO Geoff Martha called the separation an important milestone for both companies. He said each now has a clear strategic focus, with Medtronic putting its resources behind its Cardiovascular, Neuroscience and Surgical portfolios.
Newly issued MiniMed shares will be credited in book-entry form to the accounts of shareholders whose Medtronic shares were accepted in the exchange. The exchange agent will aggregate fractional shares and sell them in the open market, with cash payments sent afterward. Goldman Sachs & Co. LLC and BofA Securities acted as dealer managers for the offer.
why it matters
For the market, this confirms a separation that was already known rather than announcing a new decision. Investors will focus on MiniMed's first standalone results, its outlook, the size of its free float, and how the ownership structure of both companies changes after the spin-off.
tags
instruments
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗